Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Neha Pancholy"'
Autor:
Chun Wang, Frederick M. Fellin, Darayus Toorkey, Kaelan Yao, Neha Pancholy, Saveri Bhattacharya, Maysa M. Abu-Khalaf, Ronald E. Myers, Rebecca Jaslow, Daniel P. Silver, Zhong Ye, AnaMaria Lopez, Hushan Yang, Zhenchao Zhang
Publikováno v:
Cancer Research. 80:P6-10
Background: Circulating tumor cells (CTCs) and their clusters (CTC-clusters) are promising prognostic markers in breast cancer. Recently studies showed that platelets interact with tumor cells in the circulation and promote metastasis. However, no st
Autor:
Suhail M. Ali, Hyma Polimera, Kim Leitzel, Walter P. Carney, Elizabeth O’Day, W. Koestler, Leah Cream, Ashok Maddukuri, Bo Zhang, Allan Lipton, Chen Dong, Harry Menon, Vinod Nagabhairu, Prashanth Reddy Moku, Joseph J. Drabick, Neha Pancholy, Xiajian Shi, Monali Vasekar, Haiwei Gu
Publikováno v:
Cancer Research. 80:P4-10
Background: Cancer cells have altered metabolism, which contributes to their ability to proliferate, survive in unusual microenvironments, and invade other tissues. Measuring the complete set of metabolites in an individual (i.e. the metabolome) prov
Autor:
Suhail M. Ali, Hyma Polimera, Prashanth Reddy Moku, Liting Zhu, Aamnah Ali, Kim Leitzel, Samuel Aparicio, Karen A. Gelmon, Ashok Maddukuri, Bingshu E. Chen, Joyson Poulose, SE Halstead, Todd Umstead, WE Parulekar, Howard Spiegel, Neha Pancholy, Leah Cream, Lois E. Shepherd, D Mckeone, Joseph J. Drabick, Dora Nomikos, Allan Lipton, Shakeel Virk, Vinod Nagabhairu
Publikováno v:
Cancer Research. 79:PD3-10
Background: In the CCTG (Canadian Clinical Trials Group) MA.31 randomized phase 3 trial, the trastuzumab-taxane combination led to longer PFS than lapatinib-taxane in HER2-positive metastatic breast cancer (MBC). We previously reported the prognostic